Article
Asymmetric PCR-based strategy for genetic analysis of the p53 tumor suppressor gene in cell lines and tumor tissues.
Neoplasma - 1 Jan 1991
Bártek J, Iggo R, Vojtĕsek B, Lane D P
Abstract excerpt
A novel strategy for genetic analysis of the p53 tumor suppressor gene is described, based on direct sequencing of the asymmetric polymerase chain reaction (PCR) products. A set of 10 PCR primers was designed which allows to amplify and sequence highly conserved regions of the molecule, i.e. the target areas of p53 mutations. The stepwise optimization of RNA isolation, cDNA synthesis, PCR amplifications and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
